Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ABT vs MRNA✓SelectedUSD · MRNAABT vs MRNA performance historyLatest closeAs of-0.84%11/20
Stock and ETF performance explorer

ABT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+70.6%
MRNA return
+786.4%
Excess return
-715.8%
Maximum drawdown
-39.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.8%-2.2%+1.3%-0.8%
7D-5.1%-12.7%+7.6%-4.6%
30D+2.5%-20.7%+23.1%+3.2%
3M-9.2%+46.3%-55.5%-10.9%
6M+18.1%+305.2%-287.1%+6.8%
YTD-15.7%+561.2%-577.0%-26.8%
1Y-14.9%+772.1%-786.9%-27.6%
3Y+8.4%+147.0%-138.6%-2.2%
5Y-10.3%-26.1%+15.8%-14.2%
All+70.6%+786.4%-715.8%+35.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling